NewsRoom Articles - Page 943 of 1466

MondayMar 18, 2019 5:00 pm

MedMen (CSE: MMEN) (OTCQX: MMNFF) Attends 31st Annual ROTH Conference

MedMen (CSE: MMEN) (OTCQX: MMNFF) is a leading cannabis company in the U.S. with assets and operations across the country. The company owns and operates 19 cutting-edge facilities touching the whole vertical from cultivation to manufacturing to retail in Arizona, California, Florida, Nevada and New York. With 1,000+ employees and a fast-growing footprint that includes expansion plans in other key states and Canada. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws. For more information, visit the company's website at www.medmen.com. About NetworkNewsWire…

MondayMar 18, 2019 5:00 pm

MediPharm Labs Corp. (TSX.V: LABS) (OTCQB: MLCPF) Attends 31st Annual ROTH Conference

MediPharm Labs (TSX.V: LABS) (OTCQB: MLCPF) is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production. MediPharm Labs provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. For more information, visit the company's website at www.medipharmlabs.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news…

MondayMar 18, 2019 5:00 pm

McEwen Mining Inc. (NYSE: MUX) Attends 31st Annual ROTH Conference

McEwen Mining (NYSE: MUX) has the goal to qualify for inclusion in the S&P 500 Index by creating a profitable gold and silver producer focused in the Americas. McEwen's principal assets consist of the San José mine in Santa Cruz, Argentina (49% interest); the Black Fox mine in Timmins, Canada; the Fenix Project in Mexico; the Gold Bar mine in Nevada; and the large Los Azules copper project in Argentina, advancing towards development. For more information, visit the company's website at www.mcewenmining.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a…

MondayMar 18, 2019 4:30 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) Attends 31st Annual ROTH Conference

AzurRx BioPharma (NASDAQ: AZRX) is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. MS1819 recombinant lipase for exocrine pancreatic insufficiency is the company's lead development program, and additional early stage research is being conducted for the prevention of hospital-acquired infections. The company is headquartered in Brooklyn, NY, with scientific operations based in Langlade, France. For more information, visit the company's website at www.azurrx.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets,…

MondayMar 18, 2019 4:30 pm

Auryn Resources Inc. (NYSE American: AUG) Attends 31st Annual ROTH Conference

Auryn Resources (NYSE American: AUG) is a technically driven junior mining exploration company focused on delivering shareholder value through project acquisition and development. The company’s management team is highly experienced with an impressive track record of success and has assembled an extensive technical team as well as a premier gold exploration portfolio. Auryn is focused on scalable high-grade gold deposits in established mining jurisdictions, which include the Committee Bay and Gibson MacQuoid gold projects located in Nunavut, the Homestake Ridge gold project in British Columbia and a portfolio of gold projects in southern Peru, through Corisur Peru SAC. For more…

MondayMar 18, 2019 4:30 pm

aTyr Pharma Inc. (NASDAQ: LIFE) Attends 31st Annual ROTH Conference

aTyr Pharma (NASDAQ: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes. aTyr is focused on the therapeutic translation of the Resokine pathway, comprised of extracellular proteins derived from the histidyl tRNA synthetase gene family. For more information, visit the company's website at www.atyrpharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…

MondayMar 18, 2019 4:30 pm

Attunity Ltd. (NASDAQ: ATTU) Attends 31st Annual ROTH Conference

Attunity (NASDAQ: ATTU) provides data integration and big data management software solutions that enable availability, delivery and management of data across heterogeneous enterprise platforms, organizations and the cloud. The company’s software solutions include data replication and distribution, test data management, change data capture (CDC), data connectivity, enterprise file replication (EFR), managed file transfer (MFT), data warehouse automation, data usage analytics and cloud data delivery. Attunity has supplied innovative software solutions to its enterprise-class customers for over 20 years and has successful deployments at thousands of organizations worldwide. For more information, visit the company's website at www.attunity.com. About NetworkNewsWire NetworkNewsWire (NNW)…

MondayMar 18, 2019 4:30 pm

MaxLinear Inc. (NYSE: MXL) Attends 31st Annual ROTH Conference

MaxLinear (NYSE: MXL) delivers high-performance broadband and networking semiconductors based on its highly integrated radio frequency analog technology, high-performance optical networking technology and its pioneering MoCA and Direct Broadcast Satellite ODU single-wire technology. The company is a leading provider of radio frequency (RF), analog and mixed-signal integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multimarket applications. For more information, visit the company's website at www.maxlinear.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and…

MondayMar 18, 2019 4:30 pm

Matinas BioPharma Holdings Inc. (NYSE American: MTNB) Attends 31st Annual ROTH Conference

Matinas BioPharma (NYSE American: MTNB) is a clinical-stage biopharmaceutical company focused on (i) the development of MAT9001 for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular and metabolic disease, and (ii) enabling the delivery of life-changing medicines using the company’s proprietary, lipid nano-crystal (“LNC”) platform technology, including development of MAT2203, the company’s lead antifungal platform drug candidate. In addition, the company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate small molecules, nucleic acid polymers, vaccines and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. For more information, visit the…

MondayMar 18, 2019 4:30 pm

MariMed Inc. (MRMD) Attends 31st Annual ROTH Conference

MariMed (OTCQB: MRMD) is a multi-state cannabis company that develops, owns and operates licensed cannabis facilities and develops and distributes branded cannabis and hemp product lines. MariMed’s team has developed state-of-the-art regulatory-compliant facilities in Delaware, Illinois, Nevada, Maryland and Rhode Island, which are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision-dosed branded cannabis and hemp-derived products for the treatment of specific medical conditions. MariMed currently distributes its branded products in approximately 10 states, and is expanding licensing and distribution to additional markets, encompassing thousands of dispensaries…